¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multisubstrate enzyme system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • ecological system
    »ýŰè
  • family system theory
    °¡Á·Ã¼°è·Ð
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡
  • general system theory
    ÀϹÝü°è·Ð
  • genital system
    »ý½Ä°èÅë, »ý½Ä°è, »ý½Ä±â°è
  • genitourinary system
    ºñ´¢»ý½Ä°èÅë, ºñ´¢»ý½Ä°è
  • Haversian system
    ÇϹö½º°è
  • health care delivery system
    ÀÇ·áÀü´Þü°è
  • hypophyseal portal system
    ³úÇϼöü¹®¸Æ°è
  • health care system
    º¸°ÇÀÇ·áü°è
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è
  • hematopoietic system
    Ç÷±¸Çü¼º°èÅë, Á¶Ç÷°è
  • hospital information system
    º´¿øÁ¤º¸Ã¼°è
  • immobilization system
    °íÁ¤¹æ½Ä
  • immune system
    ¸é¿ªÃ¼°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • control system
    Á¦¾îÀåÄ¡
  • cortically originating extrapyamidal system
    °ÑÁú±â¿øÇǶó¹Ô¹Ù±ù·Î°èÅë, ÇÇÁú¹ßÃßü¿Ü·Î°è
  • countercurrent system
    ¿ª·ù°è
  • countercurrent exchanger system
    ¿ª·ù±³È¯°è
  • countercurrent multiplier system
    ¿ª·ùÁõÆø°è
  • culture system
    ¹è¾ç½Ã½ºÅÛ
  • digestive system
    ¼ÒÈ­°èÅë
  • display system
    Ç¥½ÃÀåÄ¡
  • distric health system
    Áö¿ªº¸°Çü°è
  • drug delivery system
    ¾à¹°Àü´Þü°è
  • dual foil system
    ÀÌÁß¹Ú¸·±¸Á¶
  • dynamic system
    µ¿Àû°èÅë
  • ecological system
    »ýŰè
  • electro transfer system
    ÀüÀÚÀü´Þ°è, ÀüÀÚ¿î¹Ýü
  • electro-optical system
    Àü±â±¤Çкм®°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡(μڦðàïÚíûöÇ).
  • general system theory
    ÀϹÝü°è(ÀÌ)·Ð(ìéÚõô÷ͧìµÖå)
  • genital system
    »ý½Ä°è(ßæãÖͧ).
  • genital system
    »ý½Ä°èÅë
  • genital system
    »ý½Ä±â°è(ßæãÖÐïͧ)
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
  • glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
  • global budget system
    ÃѾ׿¹»êÁ¦, ÃѾװè¾àÁ¦.
  • guarantee system
    º¸ÁõÁ¦µµ(ËÓ̡̡̬).
  • h2o2-myeloperxidase-halide system
    °ú»êÈ­¼ö¼Ò-°ñ¼ö°ú»êÈ­È¿¼Ò-ÇÒ·Î°Õ °èÅë
  • hamatopoietic system
    Á¶Ç÷±â°ü(ðãúìÐïί)
  • health care delivery system
    ÀÇ·áÀü´ÞÁ¦µµ(ËöËíËøËÀ̡̬).
  • health care system
    º¸°ÇÀÇ·áü°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • packaging enzyme
    ²Ù¸®±âÈ¿¼Ò
  • pancreatic enzyme
    ÃéÀåÈ¿¼Ò.
  • pancreatic enzyme
    ÃéÈ¿¼Ò(õýý£áÈ).
  • periplasmic enzyme
    ¿øÇüÁú¸· ÁÖÀ§°ø°£ È¿¼Ò
  • phosphorylating enzyme
    ÀλêÈ­È¿¼Ò(ìÝß« ûùý£áÈ).
  • prosthetic group-labeled enzyme
    º¸Á¶±ºÇ¥ÁöÈ¿¼Ò
  • proteolytic enzyme
    ´Ü¹éÁú°¡¼öºÐÇØÈ¿¼Ò.
  • proteolytic enzyme
    ´Ü¹éÁúºÐÇØÈ¿¼Ò
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò(áÜöôðàï½ý£áÈ).
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò(¡­÷òÎÕý£áÈ).
  • redox enzyme
    »êȭȯ¿øÈ¿¼Ò(ß«ûùü»êªý£áÈ).
  • reducing enzyme
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • regulatory enzyme
    Á¶ÀýÈ¿¼Ò(¡­ý£áÈ).
  • respiration enzyme
    È£ÈíÈ¿¼Ò(û¼ýåý£áÈ).
  • respiratory enzyme
    È£ÈíÈ¿¼Ò.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • DNA restriction enzyme
    DNA Á¦ÇÑ È¿¼Ò(ð¤ùÚý£áÈ) (ÔÒ) restriction enzyme
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • early enzyme
    Á¶±â È¿¼Ò(ðÄÑ¢ý£áÈ)
  • enzyme
    È¿¼Ò(ý£áÈ)
  • enzyme I
    È¿¼Ò(ý£áÈ) I
  • enzyme II
    È¿¼Ò(ý£áÈ) II
  • enzyme III
    È¿¼Ò(ý£áÈ) III
  • enzyme adaptation
    È¿¼Ò ÀûÀÀ(ý£áÈîêëë)
  • enzyme amplification
    È¿¼Ò ÁõÆø(ý£áÈñòøë)
  • enzyme analogue
    È¿¼ÒÀ¯»çü(ý£áÈëºÞÄô÷)
  • enzyme assay
    È¿¼Ò(ý£áÈ)¾Æ½êÀÌ
  • enzyme-bridge complex
    È¿¼Ò°¡±³ º¹ÇÕü (ý£áÈÊ­ÎéÜÜùêô÷)
  • enzyme cascade
    È¿¼Ò(ý£áÈ) ÄɽºÄÉÀ̵å
  • enzyme classification
    È¿¼Ò ºÐ·ù(ý£áÈÝÂ×¾)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ACE acetonitrile; acetylcholine esterase; acute cerebral encephalopathy; acute coronary event; adrenocor...
ACEDS angiotensin-converting enzyme dysfunction syndrome
ACEI angiotensin-converting enzyme inhibitor
AICE angiotensin I converting enzyme
CE California encephalitis; cardiac enlargement; cardioesophageal; carotid endarterectomy; catamenial e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
EITB Enzyme Linked Immunoelectro Transfer Blot
ELLA Enzyme Linked Lectin Assay
ELIFA Enzyme Linked immunofiltration Assay
EMIT Enzyme Multiplied Immuno-assay Technique
ELISA Enzyme immunoassay
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • implant system
    ÀÓÇöõÆ® ½Ã½ºÅÛ
  • improved classificaion system
    °³¼±µÈ ºÐ·ù ü°è
  • kinesodic system
    ô¼ö ¿îµ¿°è
  • kinetic system
    ¿îµ¿°è
    ³ú, °©»ó¼±, ºÎ½Å, °£, ÃéÀå µîÀÇ ±â°ü°èÅëÀ¸·Î, ÀáÀç·ÂÀ» ¿îµ¿°ú ¿­·Î º¯È­½ÃŰ´Â ±â´ÉÀ» ³ªÅ¸³½´Ù. ´Éµ¿Àû ¿îµ¿À» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ½Å°æ±Ù°è.
  • lacrimal system
    ´«¹° ±â°ü
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • lymphatic system
    ¸²ÇÁ°è
    °¨¿°À̳ª Áúº´°ú ½Î¿ì´Â ¼¼Æ÷¸¦ ¸¸µé°Å³ª ÀúÀåÇÏ´Â Á¶Á÷°ú Àå±â. °ñ¼ö, ºñÀå, Èä¼±, ±×¸®°í ¸²ÇÁÀý µîÀÌ ¸²ÇÁ°èÀÇ ´ëÇ¥Àû Àå±âÀÌ´Ù. ¸²ÇÁ°è¿¡´Â ÀÌ·¯ÇÑ ¿©·¯ Á¶Á÷°ú Àå±â¸¦ ¿¬°áÇÏ´Â Åë·Î Áï ¸²ÇÁ°üÀÌ ÀÖÀ¸¸ç À̸¦ ÅëÇØ ¸²ÇÁ°¡ ¿î¹ÝµÈ´Ù.
  • lymphoreticular system
    ¸²ÇÁ ¼¼¸Á ³»Çǰè
  • masticatory musculoskeletal system
    ÀúÀÛ±Ù °ñ°Ý°è
  • masticatory system
    ÀúÀÛ°è
    Ä¡¾Æ, Ä¡ÁÖ Á¶Á÷, ¾Ç°ñ, ÃøµÎÇϾǰüÀý, ÀúÀÛ±Ù ÀÔ¼ú, Çô ¹× À̵é Á¶Á÷°ú °ü·ÃµÈ Ç÷°ü, ½Å°æµé·Î ÀÌ·ç¾îÁø ±â´ÉÀû ´ÜÀ§.
  • mating system
    ±³¹è ½Ã½ºÅÛ
  • metric system
    ¹ÌÅ͹ý
  • monochromatic system
    ´Ü»ö°è
  • monocyte-macrophage system
    ´ÜÇÙ±¸-´ë½Ä ¼¼Æ÷°è
  • monovalent system
    ÀϺ¯°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
enzyme precursor <biochemistry> Inactive precursors that can be converted to active enzymes.
Enzyme precursors containing extra-long polypeptide chains that block activity are activated by acid or enzymatic hydrolysis to remove the inhibiting portion.
(12 Dec 1998)
enzyme reactivator <biochemistry> Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme.
(12 Dec 1998)
enzyme regulation <biochemistry> Control of the rate of a reaction catalyzed by an enzyme by some effector (e.g., inhibitors or activators) or by alteration of some condition (e.g., pH or ionic strength).
(05 Mar 2000)
enzyme replacement therapy A type of medical treatment for patients who lack an important enzyme, the missing enzyme is injected into the patient.
(09 Oct 1997)
enzyme repression The interference in synthesis of an enzyme due to the elevated level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis.
(12 Dec 1998)
enzymes, coenzymes, and enzyme inhibitors Proteins or RNA that act as biological catalysts, their cofactors, and inhibitors.
(12 Dec 1998)
enzyme stabilisation Reducing the chances that an enzyme will inactivate in vitro (see enzyme inactivation) by changing the environmental conditions (such as pH, temperature, concentration of salt, etc.) or by attaching organic groups to it or changing some of its amino acid subunits.
(09 Oct 1997)
enzyme stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat.
(12 Dec 1998)
enzyme-substrate complex A noncovalent complex of two molecules; often referring to the enzyme-substrate complex in an enzyme-catalyzed reaction.
Compare: central complex, Michaelis complex.
Synonym: enzyme-substrate complex.
(05 Mar 2000)
extracellular enzyme <enzyme> An enzyme performing its functions outside a cell; e.g., the various digestive enzyme's.
Synonym: exoenzyme, lyoenzyme.
(05 Mar 2000)
yellow enzyme Any enzyme that possesses a flavin nucleotide as coenzyme; e.g., xanthine oxidase, succinate dehydrogenase.
Synonym: yellow enzyme.
(05 Mar 2000)
UDP-N-acetylglucosamine-lysosomal-enzyme-N-acetylglucosaminephosphotransferase <enzyme> Fibroblasts from patients with i-cell (mucolipidosis II) and pseudo-hurler polydystrophy (mucolipidosis III) are deficient in above enzyme; for n-acetylglucosamine transferred to dolichyl phosphate see EC 2.7.8.15
Registry number: EC 2.7.8.17
Synonym: udpgnac gp gnac phosphotransferase, udpgnac phosphotransferase, uridine 5'-diphosphate-n-acetylglucosamine glycoprotein n-acetylglucosaminylphosphotransferase, n-acetylglucosamine-1-phosphotransferase, n-agapt, udp-n-acetylglucosamine-lysosomal glycoprotein n-acetylglucosaminylphosphotransferase, udp-acetylglucosamine-glycoprotein n-acetylglucosamine-1-phosphotransferase
(26 Jun 1999)
UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosaminyl-1-phosphotransferase <enzyme> An enzyme that participates in the posttranslational modification of a number of lysosomal proteins; a deficiency or defect in this enzyme results in two forms of mucolipidoses, I-cell disease, and pseudo-Hurler polydystrophy.
(05 Mar 2000)
Kornberg enzyme DNA polymerase I from Escherichia coli.
(05 Mar 2000)
1,4-alpha-glucan branching enzyme <enzyme> In glycogen or amylopectin synthesis, the enzyme that catalyses the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain.
Chemical name: 1,4-alpha-D-Glucan:1,4-alpha-D-glucan 6-alpha-D-(1,4-alpha-D-glucano)-transferase
Registry number: EC 2.4.1.18
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • real-time system
    ½Ç½Ã°£(Áï½Ãó¸®)½Ã½ºÅÛ(´Ü¸»¿¡¼­ º¸³»¿Â µ¥ÀÌÅ͸¦ Áï½Ã ÄÄÇ»ÅÍ¿¡ ó¸®ÇÏ¿© ´Ü¸»·Î µÇµ¹¸®´Â ½Ã½ºÅÛ)
  • remote manipulator system
    ¿ø°Ý Á¶ÀÛ ½Ã½ºÅÛ
  • respiratory system
    È£Èí±â°è
  • reticuloendothelial system
    (¼¼)¸Á ³»(ÇÇ)°è
  • retrieval system
    Á¤º¸ °Ë»ö ½Ã½ºÅÛ
  • solar system
    žç°è
  • spoils system
    ¿±°ü Á¦µµ(¿©´çÀÌ Â÷ÁöÇÏ´Â)
  • sprinkler system
    ÀÚµ¿ »ì¼ö ¼ÒÈ­ ÀåÄ¡
  • stagger system
    (ÃâÅð±Ù ½Ã°£ µûÀ§ÀÇ)½ÃÂ÷Á¦
  • system
    Á¶Á÷;ü°è;°èÅë;Çм³;Á¦µµ;¹æ½Ä;¹æ¹ý;¼ø¼­;°è;¿ìÁÖ
  • talkingdown system
    ¹«Àü À¯µµ ¹æ½Ä
  • track system
    Çзº° ¹ÝÆí¼º
  • truck system
    (ÀÓ±ÝÀÇ) Çö¹° Áö±ÞÁ¦
  • twoparty system
    2´ë Á¤´çÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á